Phenomenex Appoints New CEO
Kaveh Kahen, PhD, has been appointed president of Phenomenex, the Torrance, California-based separation science technology company, according to a press release. Kahen succeeds Matt Turner, who moved on from the Phenomenex presidency to pursue other opportunities, the company said.
Phenomenex operates within the Life Sciences group of Danaher Corporation, making this a homecoming of sorts for Kahen. After obtaining his PhD in analytical chemistry from The George Washington University, he began his professional career at Sciex, another Danaher Life Sciences holding.
Following his tenure at Sciex, Kahen held various leadership posts at PerkinElmer, according to the release, and more recently was CEO at Advion Interchim Scientific. Kahen designed and developed new technologies and instruments early in his career, and later as an executive gained a reputation for driving above-market growth in the fields of life sciences, analytical testing, and laboratory equipment, according to the release.
Evaluating Body Odor Sampling Phases Prior to Analysis
April 23rd 2025Researchers leveraged the advantages of thermodesorption, followed by comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GC×GC/TOF-MS), to compare and assess a variety of sampling phases for body odor.
